Skip Nav Destination
1-1 of 1
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL
Clinical Trials & Observations
Journal: Blood Advances
Blood Adv (2018) 2 (7): 762–768.